Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines

Jamie R Wood, Kellee M Miller, David M Maahs, Roy W Beck, Linda A DiMeglio, Ingrid M Libman, Maryanne Quinn, William V Tamborlane, Stephanie E Woerner, T1D Exchange Clinic Network

Abstract

Objective: To assess the proportion of youth with type 1 diabetes under the care of pediatric endocrinologists in the United States meeting targets for HbA1c, blood pressure (BP), BMI, and lipids.

Research design and methods: Data were evaluated for 13,316 participants in the T1D Exchange clinic registry younger than 20 years old with type 1 diabetes for ≥1 year.

Results: American Diabetes Association HbA1c targets of <8.5% for those younger than 6 years, <8.0% for those 6 to younger than 13 years old, and <7.5% for those 13 to younger than 20 years old were met by 64, 43, and 21% of participants, respectively. The majority met targets for BP and lipids, and two-thirds met the BMI goal of <85th percentile.

Conclusions: Most children with type 1 diabetes have HbA1c values above target levels. Achieving American Diabetes Association goals remains a significant challenge for the majority of youth in the T1D Exchange registry.

Figures

Figure 1
Figure 1
A: Proportion of participants meeting HbA1c targets (N = 13,226). ADA (black bars): <8.5% for those 1 to younger than 6 years of age, <8.0% for those 6 to younger than 13 years of age, and <7.5% for those 13 to younger than 20 years of age. ISPAD (striped bars): <7.5%. B: Proportion of participants meeting BP target (N = 12,664) <90th percentile for age, sex, and height. C: Proportion of participants meeting BMI target (N = 13,045) <85th percentile for age and sex. BMI percentile was not calculated for those younger than 2 years of age. D: Proportion of participants meeting fasting LDL target (N = 3,010) <100 mg/dL (<2.6 mmol/L). E: Proportion of participants meeting HDL target (N = 8,938). ADA (black bars): >35 mg/dL; ISPAD (striped bars): >1.1 mmol/L. F: Proportion of participants meeting triglycerides target (N = 2,454) <150 mg/dL (<1.7 mmol/L).

References

    1. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–986
    1. Nathan DM, Cleary PA, Backlund JY, et al. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643–2653
    1. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 2003;290:2159–2167
    1. Libman IM, Pietropaolo M, Arslanian SA, LaPorte RE, Becker DJ. Changing prevalence of overweight children and adolescents at onset of insulin-treated diabetes. Diabetes Care 2003;26:2871–2875
    1. Liu LL, Lawrence JM, Davis C, et al. SEARCH for Diabetes in Youth Study Group Prevalence of overweight and obesity in youth with diabetes in USA: the SEARCH for Diabetes in Youth study. Pediatr Diabetes 2010;11:4–11
    1. Rodriguez BL, Dabelea D, Liese AD, et al. SEARCH Study Group Prevalence and correlates of elevated blood pressure in youth with diabetes mellitus: the SEARCH for diabetes in youth study. J Pediatr 2010;157:245–251, e1
    1. Dahl-Jørgensen K, Larsen JR, Hanssen KF. Atherosclerosis in childhood and adolescent type 1 diabetes: early disease, early treatment? Diabetologia 2005;48:1445–1453
    1. Silverstein J, Klingensmith G, Copeland K, et al. American Diabetes Association Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. Diabetes Care 2005;28:186–212
    1. American Diabetes Association Standards of medical care in diabetes—2012. Diabetes Care 2012;35(Suppl. 1):S11–S63
    1. American Diabetes Association Management of dyslipidemia in children and adolescents with diabetes. Diabetes Care 2003;26:2194–2197
    1. Donaghue KC, Chiarelli F, Trotta D, Allgrove J, Dahl-Jorgensen K, International Society for Pediatric and Adolescent Diabetes ISPAD clinical practice consensus guidelines 2006-2007. Microvascular and macrovascular complications. Pediatr Diabetes 2007;8:163–170
    1. Beck RW, Tamborlane WV, Bergenstal RM, Miller KM, DuBose SN, Hall CA. The T1D Exchange Clinic Registry. J Clin Endocrinol Metab 2012;97:4383–438910.1210/jc.2012-156113
    1. Maahs DM. Cardiovascular disease (CVD) limbo: how soon and low should we go to prevent CVD in diabetes? Diabetes Technol Ther 2012;14:449–452
    1. Herbst A, Kordonouri O, Schwab KO, Schmidt F, Holl RW, DPV Initiative of the German Working Group for Pediatric Diabetology Germany Impact of physical activity on cardiovascular risk factors in children with type 1 diabetes: a multicenter study of 23,251 patients. Diabetes Care 2007;30:2098–2100

Source: PubMed

Подписаться